Yuanming Shen

9PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisTumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 19, 2026
Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial.

|May 02, 2026
Efficacy of Fertility-Sparing Treatment With Progestin Is Associated With Different Molecular Classification in Endometrial Carcinoma and Atypical Endometrial Hyperplasia.

|Feb 19, 2026
Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trial.

Yuanming Shen, Nalan Tu, Beihua Kong

|Dec 30, 2023
Secondary cytoreduction surgery for recurrent epithelial ovarian cancer patients after PARPi maintenance: A multicenter, randomized, controlled clinical trial.

Tingting Chen, Junfen Xu, Bairong Xia

|Nov 09, 2023
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study.

Tingting Chen, Junfen Xu, Bairong Xia

|Mar 31, 2023
Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).

Misi He, Mingfang Guo, Qi Zhou

Pageof 2

Frequent Collaborators

3 joint publications

Junfen Xu

3 joint publications

Tingting Chen

2 joint publications

Nalan Tu

2 joint publications

Weiguo Lv